High-yield points
- MOMS (repair before 26 weeks, hysterotomy):
- Shunts 40% vs. 82%.
- Hindbrain herniation 64% vs. 96%.
- Independent ambulation 45% vs. 24%.
- Cost: prematurity (mean 34 weeks; 13% born before 30 weeks), membrane rupture 46%, and a thin or dehisced hysterotomy in about a third .
- Selection:
- Lesion T1–S1, hindbrain herniation, 19–26 weeks, maternal BMI under 35, no severe kyphosis, and no high preterm risk.
- Fetoscopic centers increasingly operate up to about 27 weeks .
- Open vs. fetoscopic:
- Fetoscopic avoids uterine scar dehiscence (0% vs. 34–49%) and allows vaginal birth .
- It has more repair-site leak or dehiscence, and percutaneous approaches have more membrane rupture and prematurity .
- Shunt and Chiari reversal rates are similar .
- Future pregnancies after open repair: dehiscence 14% and rupture 14%. Cesarean delivery is mandatory .
- Long term:
- Bladder: less CIC (62% vs. 87%) and more volitional voiding at school age .
- Shunt revisions: fewer .
- Cognition: no gain .
- Tethering: a possible increase (8% vs. 1% in MOMS), so follow for life .
Landmark papers
- MOMS (Adzick et al., N Engl J Med 2011): a randomized trial of prenatal vs postnatal myelomeningocele repair. At 12 months, shunt placement was 40% vs 82% and any hindbrain herniation was 64% vs 96% .
- MOMS full cohort (Farmer et al., Am J Obstet Gynecol 2018): at 30 months, independent ambulation was 44.8% vs 23.9% with prenatal vs postnatal repair, and cognitive scores did not differ .
- International Fetoscopic Consortium (Sanz Cortes et al., Am J Obstet Gynecol 2021): a registry of 300 fetoscopic repairs. Uterine scar dehiscence or thinning was 0% vs 34% (MOMS) and 49% (post-MOMS open cohort) .
The Management of Myelomeningocele Study (MOMS) showed that repair before 26 weeks, through a hysterotomy, halves the need for shunting and improves motor function compared with postnatal repair. The cost is prematurity and uterine-scar risk . Fetoscopic techniques aim to keep the neurologic benefit while protecting the mother and future pregnancies .
Patient selection
- MOMS inclusion :
- A singleton fetus with myelomeningocele, upper level T1 to S1.
- Hindbrain herniation present.
- 19.0–25.9 weeks at randomization.
- Normal karyotype.
- Maternal age 18 or older (US residency was required for the trial).
- MOMS exclusion :
- A fetal anomaly unrelated to the myelomeningocele.
- Severe kyphosis.
- High risk of preterm birth (short cervix, prior preterm birth).
- Placental abruption.
- Maternal BMI of 35 or higher.
- A contraindication to surgery, including a prior hysterotomy in the active uterine segment.
- Evolving criteria:
- Fetoscopic programs: they use MOMS criteria but often operate later .
- Late surgery: in 94 fetuses repaired percutaneously at a median of 27.0 weeks, motor function did not change over the 4 weeks before surgery .
- Prenatal motor level: ultrasound assessment of motor function predicted postnatal function better than the anatomic level .
- Prognostic factors for shunting: ventricular size and lesion type (myeloschisis) predicted the need for CSF diversion after fetoscopic repair .
Technical differences
- Open (hysterotomy) repair :
- Maternal laparotomy, an exteriorized uterus, and a hysterotomy of about 6–8 cm placed away from the placenta.
- Direct microsurgical layered closure of the placode, dura and skin.
- Every later delivery, including this one, must be by cesarean section .
- Fetoscopic repair:
- Laparotomy-assisted, two ports (Belfort): the uterus is exteriorized and filled with CO₂ .
- Operating time is long (about 250 minutes), and vaginal delivery is possible .
- A three-layer closure (bovine collagen patch, myofascial layer, skin) cut CSF leak at birth from 25% to 0% compared with single-layer closure. It also improved hindbrain herniation reversal at 6 weeks (93% vs. 60%) .
- Percutaneous (SAFER and similar): ports go through the maternal skin. A biocellulose patch is placed between the placode and the skin or myofascial flap, without suturing the dura .
- Meta-analyses :
- Fetoscopic surgery takes longer (220 vs. 134 minutes).
- Wound dehiscence or CSF leakage at the repair site is more common: 30% vs. 7% , and 13.7% vs. 4.3% .
Maternal outcomes and complications
- MOMS, prenatal vs. postnatal repair :
- Pregnancy complications:
- Chorioamniotic membrane separation: 26% vs. 0%.
- Spontaneous membrane rupture: 46% vs. 8%.
- Oligohydramnios: 21% vs. 4%.
- Spontaneous labor: 38% vs. 14%.
- Placental abruption: 6% vs. 0%.
- Maternal pulmonary edema: 6% vs. 0%.
- Blood transfusion at delivery: 9% vs. 1%.
- Hysterotomy at delivery:
- Very thin in 25%.
- Partial dehiscence in 9%.
- Complete dehiscence in 1%.
- Risk factors :
- Earlier gestational age at surgery and membrane separation predicted membrane rupture.
- Oligohydramnios predicted preterm delivery (OR 9.2).
- Nulliparity predicted a non-intact hysterotomy (OR 3.7).
- Future pregnancies after open fetal surgery :
- Uterine dehiscence 14% and uterine rupture 14%.
- Fertility was not reduced: 98% conceived normally.
- Fetoscopic vs. open:
- Fetoscopic registry (300 patients) vs. MOMS and a post-MOMS open cohort :
- Uterine scar dehiscence or thinning: 0% vs. 34% (MOMS) and 49% (post-MOMS).
- About one-third delivered vaginally after fetoscopic repair; all open cases needed cesarean delivery.
- Meta-analysis of 11 studies :
- Membranes and prematurity: the percutaneous approach had more premature rupture of membranes (91% vs. 36%) and more preterm birth (96% vs. 81%). The laparotomy-assisted approach reduced preterm birth.
- Uterine dehiscence: 0% after fetoscopic repair vs. 11% after open repair.
- Larger meta-analysis (32 studies), fetoscopic vs. open :
- Fetoscopic repair had more premature rupture of membranes (52% vs. 30%) and oligohydramnios (49% vs. 15%).
- Placental abruption rates were similar (4.2% vs. 3.2%).
Fetal and neonatal outcomes and complications
- Prematurity is the main fetal cost of open repair in MOMS :
- Mean gestational age at birth 34.1 vs. 37.3 weeks.
- Born before 30 weeks: 13% vs. 0%.
- Born before 37 weeks: 79% vs. 15%.
- Perinatal death: 3% vs. 2%, not different .
- Both prenatal-group deaths were from prematurity, on postoperative day 5.
- Both postnatal-group deaths were in infants with severe Chiari II symptoms.
- Fetoscopic registry: perinatal death and mean gestational age at delivery were similar to open repair .
- Repair-site problems: CSF leak and dehiscence are more common after fetoscopic repair . Leak rates depend on technique .
Long-term outcomes
- Hydrocephalus and shunting:
- MOMS, at 12 months: shunt placement 40% vs. 82% . In the full cohort it was 44% vs. 84% .
- Shunt revision by 1 year: 15.4% vs. 40.2% .
- School age (5.9–10.3 years): shunted 49% vs. 85%. Revision among shunted children was 47% vs. 70% .
- Fetoscopic repair:
- No difference vs. open at 12 months , or across meta-analyses (42% vs. 39%) .
- SAFER: 53.4% needed no shunt or ETV at 12 months .
- Chiari II (hindbrain herniation):
- MOMS, at 12 months: any herniation 64% vs. 96%. Moderate or severe herniation 25% vs. 67% .
- School age: 60% vs. 87% .
- Reversal rates are similar for fetoscopic and open repair (58% vs. 60%) .
- Motor function and ambulation:
- MOMS full cohort, at 30 months: independent ambulation 44.8% vs. 23.9%. Function was at least two levels better than the anatomic level in 26.4% vs. 11.4%. Cognitive scores did not differ .
- School age: walking without orthotics 29% vs. 11% (P = .06). Better mobility and self-care, but no difference in overall adaptive behavior (Vineland) .
- SAFER: 54.2% walked independently at 30 months .
- Bladder:
- MOMS urology substudy, at 30 months: CIC 38% vs. 51%, not significant. Prenatal repair showed less bladder trabeculation and fewer open bladder necks .
- School age (mean 7.4 years):
- CIC 62% vs. 87%.
- Voiding volitionally 24% vs. 4%.
- No difference in augmentation, vesicostomy or urodynamic findings.
- The authors caution that urology alone shouldn't drive the choice of fetal surgery .
- SAFER: 61% did not need CIC at 30 months .
- Bowel and continence:
- Non-randomized series of 72 children: prenatal repair was associated with better social urinary continence, fewer UTIs and less constipation .
- Caveat: randomized bowel data are limited.
- Tethered cord (retethering):
- MOMS: surgery for tethered cord 8% vs. 1% (P = .06), with more delayed tethering procedures after prenatal repair. Epidermoid cysts 3% vs. 2% .
- Meta-analysis of 2,724 patients: tethering 21.6% after prenatal vs. 18.8% after postnatal repair (RR 1.15, not significant). Restricted to RCTs and controlled cohorts, the RR was 1.31 (P = .053), a trend toward more tethering after fetal repair .
- Follow-up: watch for tethering and inclusion cysts for life.
Related topics
- Postnatal MMC Repair: the comparator and standard approach.
- Re-tethering: delayed tethering after repair.
- Surgical Options in Shunting: managing the hydrocephalus.
- ETV: endoscopic alternative to shunting in MMC.
- Efficacy of ETV-CPC in Infants: hydrocephalus after repair.
- Normal Embryological Development of the Brain and Spine: the developmental step behind this lesion.
- Bioethics: Challenging Situations in Pediatric Neurosurgery: ethical frameworks for hard decisions.
- Postnatal Myelomeningocele Repair: Procedure: step-by-step procedure.
References
- Adzick NS, Thom EA, Spong CY, et al. A randomized trial of prenatal versus postnatal repair of myelomeningocele. N Engl J Med 2011;364(11):993–1004. doi:10.1056/NEJMoa1014379. PMID 21306277. verified
- Sanz Cortes M, Chmait RH, Lapa DA, et al. Experience of 300 cases of prenatal fetoscopic open spina bifida repair: report of the International Fetoscopic Neural Tube Defect Repair Consortium. Am J Obstet Gynecol 2021;225(6):678.e1–678.e11. doi:10.1016/j.ajog.2021.05.044. PMID 34089698. verified
- Belfort MA, Whitehead WE, Shamshirsaz AA, et al. Fetoscopic open neural tube defect repair: development and refinement of a two-port, carbon dioxide insufflation technique. Obstet Gynecol 2017;129(4):734–743. doi:10.1097/AOG.0000000000001941. PMID 28277363. verified
- Kohl T. Percutaneous fetoscopic patch coverage of spina bifida aperta in the human: early clinical experience and potential. Fetal Diagn Ther 2006;21(2):185–193. doi:10.1159/000089301. PMID 16491001. verified
- Trigo L, Chmait RH, Llanes A, et al. Revisiting MOMS criteria for prenatal repair of spina bifida: upper gestational-age limit should be raised and assessment of prenatal motor function rather than anatomical level improves prediction of postnatal function. Ultrasound Obstet Gynecol 2024;63(1):53–59. doi:10.1002/uog.27536. PMID 37970655. verified
- Lapa DA, Chmait RH, Gielchinsky Y, et al. Percutaneous fetoscopic spina bifida repair: effect on ambulation and need for postnatal cerebrospinal fluid diversion and bladder catheterization. Ultrasound Obstet Gynecol 2021;58(4):582–589. doi:10.1002/uog.23658. PMID 33880811. verified
- Belfort MA, Whitehead WE, Shamshirsaz AA, et al. Comparison of two fetoscopic open neural tube defect repair techniques: single- vs three-layer closure. Ultrasound Obstet Gynecol 2020;56(4):532–540. doi:10.1002/uog.21915. PMID 31709658. verified
- Kabagambe SK, Jensen GW, Chen YJ, et al. Fetal surgery for myelomeningocele: a systematic review and meta-analysis of outcomes in fetoscopic versus open repair. Fetal Diagn Ther 2018;43(3):161–174. doi:10.1159/000479505. PMID 28910784. verified
- de Oliveira Júnior JP, Morais BA, Fernandes MNF, et al. Open repair versus fetoscopic fetal surgery: which is the best approach for intrauterine myelomeningocele correction? Systematic review and meta-analysis. Childs Nerv Syst 2025;41(1):256. doi:10.1007/s00381-025-06915-0. PMID 40779058. verified
- Johnson MP, Bennett KA, Rand L, et al. The Management of Myelomeningocele Study: obstetrical outcomes and risk factors for obstetrical complications following prenatal surgery. Am J Obstet Gynecol 2016;215(6):778.e1–778.e9. doi:10.1016/j.ajog.2016.07.052. PMID 27496687. verified
- Wilson RD, Lemerand K, Johnson MP, et al. Reproductive outcomes in subsequent pregnancies after a pregnancy complicated by open maternal-fetal surgery (1996–2007). Am J Obstet Gynecol 2010;203(3):209.e1–209.e6. doi:10.1016/j.ajog.2010.03.029. PMID 20537307. verified
- Tulipan N, Wellons JC, Thom EA, et al. Prenatal surgery for myelomeningocele and the need for cerebrospinal fluid shunt placement. J Neurosurg Pediatr 2015;16(6):613–620. doi:10.3171/2015.7.PEDS15336. PMID 26369371. verified
- Houtrow AJ, Thom EA, Fletcher JM, et al. Prenatal repair of myelomeningocele and school-age functional outcomes. Pediatrics 2020;145(2):e20191544. doi:10.1542/peds.2019-1544. PMID 31980545. verified
- Farmer DL, Thom EA, Brock JW, et al. The Management of Myelomeningocele Study: full cohort 30-month pediatric outcomes. Am J Obstet Gynecol 2018;218(2):256.e1–256.e13. doi:10.1016/j.ajog.2017.12.001. PMID 29246577. verified
- Brock JW, Carr MC, Adzick NS, et al. Bladder function after fetal surgery for myelomeningocele. Pediatrics 2015;136(4):e906–e913. doi:10.1542/peds.2015-2114. PMID 26416930. verified
- Brock JW, Thomas JC, Baskin LS, et al. Effect of prenatal repair of myelomeningocele on urological outcomes at school age. J Urol 2019;202(4):812–818. doi:10.1097/JU.0000000000000334. PMID 31075056. verified
- Pastuszka A, Bohosiewicz J, Koszutski T. Prenatal myelomeningocele repair improves urinary continence and reduces the risk of constipation. Neurourol Urodyn 2018;37(8):2792–2798. doi:10.1002/nau.23771. PMID 30058735. verified
- Spoor JKH, Kik CC, van Veelen MC, et al. Potential higher risk of tethered spinal cord in children after prenatal surgery for myelomeningocele: a systematic review and meta-analysis. PLoS One 2023;18(6):e0287175. doi:10.1371/journal.pone.0287175. PMID 37379312. verified
Verification (2026-11-03): each reference's authors, title, journal, volume, pages, DOI and PMID were checked on PubMed. The MOMS eligibility criteria, maternal complications, hysterotomy findings, gestational-age distribution, perinatal deaths, hindbrain herniation grades, tethered-cord surgery and epidermoid cyst rates were checked against the full text of reference 1 (PMC3770179). Preterm percentages before 37 weeks were summed from its table. Every other number was checked against the PubMed abstracts.
Caveats:
- The 6–8 cm hysterotomy size and the open technique description are standard practice rather than figures quoted from these abstracts.
- Reference 4 is cited for the origin of the percutaneous approach only.
- The fetoscopic data are registry and meta-analytic, not randomized, and techniques are heterogeneous (references 2, 6–9).
- Reference 17 is non-randomized.
- The figure is an original schematic.